| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |